Effects of an Arkansas strain of infectious bronchitis vaccine on the head-associated lymphoid tissue (HALT).
Chicks were vaccinated with an Arkansas strain of infectious bronchitis virus (IBV) vaccine when they were 1 day (Trial 1) or 4 weeks old (Trial 2). Starting at 4 weeks 3 days of age, chicks in both trials were subjected to an assay that measures the immunofunctional response of the gland of Harder (GH), one of the components of the head-associated lymphoid tissue (HALT). The assay involved multiple ocular exposures to killed Brucella abortus antigen, after which tears were collected and titered for antibodies to B. abortus. Following this, select tissues from vaccinated and unvaccinated chicks were collected and examined microscopically for specific lesions. Both functional and structural alterations were detected in the HALT of IBV-vaccinated chicks. Antibody titers to B. abortus in vaccinated chicks were significantly lower (P less than 0.05) than in unvaccinated controls. Structurally, there were elevations (P less than 0.01) in the number of lymphoid cells and follicles found in the mucosal lining of the nasal cavity. This occurred in the vaccinated chicks of both trials. Otherwise, histologic changes were confined to the chicks vaccinated at 4 weeks of age (Trial 2). In that trial, there were elevations in lymphoid-cell and follicle numbers in the eyelid (P less than 0.01) and lacrimal gland (P less than 0.05).
Montgomery
R D
RD
College of Veterinary Medicine, Mississippi State, Mississippi 39762.
Maslin
W R
WR
Boyle
C R
CR
Pledger
T
T
Wu
C C
CC
D000704:Analysis of Variance; D000818:Animals; D000907:Antibodies, Bacterial / Q000032:analysis; D000914:Antibodies, Viral / Q000096:biosynthesis; D001131:Arkansas; D002003:Brucella abortus / Q000276:immunology; D002645:Chickens; D006243:Harderian Gland / Q000276:immunology* / Q000382:microbiology / Q000473:pathology; D006385:Hemagglutination Inhibition Tests; D001351:Infectious bronchitis virus / Q000276:immunology*; D007765:Lacrimal Apparatus / Q000276:immunology / Q000382:microbiology / Q000473:pathology; D008221:Lymphoid Tissue / Q000276:immunology* / Q000382:microbiology / Q000473:pathology; D009297:Nasal Mucosa / Q000276:immunology / Q000382:microbiology / Q000473:pathology; D013047:Specific Pathogen-Free Organisms; D013666:Tears / Q000276:immunology; D014132:Trachea / Q000276:immunology / Q000473:pathology; D014611:Vaccination / Q000662:veterinary; D014765:Viral Vaccines / Q000276:immunology*
D000907:Antibodies, Bacterial; D000914:Antibodies, Viral; D014765:Viral Vaccines